CHAPEL HILL, NC, UNITED STATES - Sep 30, 2014 -
WHAT: Rho, a full-service contract
research organization (CRO), is showcasing its 30-year history of
success in drug development strategies and services, including
risk-based monitoring (RBM) strategies, at the Outsourcing in
Clinical Trials (OCT) New England Conference taking place October
7-8 in Boston, Massachusetts.
Attendees are invited to stop by Rhos booth (#54) to meet with
RBM expert Lauren McGurk, who has more than 17 years of experience
in all phases of development, including creating and executing RBM
plans. Risk-based approaches can actually reduce the risks in
clinical trials by focusing on the most critical data elements and
processes necessary to achieve study objectives.
McGurk will also be speaking at the event, presenting
Strategies for Clinical, Data, and Statistical Team Integration
and Planning to Improve Data Quality and Mitigate Risks. During
her talk, she will discuss the development of robust and adaptive
clinical monitoring and risk management plans; ways to establish
early communication pathways between clinical, data and statistical
team members; how to enhace quality management at the site level to
support risk-based strategies; and explore the use of web portals
to enhance study management.
WHO: Rho expert(s) at OCT:
- Lauren McGurk, Senior Clinical Research Associate II
- Jessica Barons, Director, Business Development
WHEN: October 7-8, 2014
WHERE: Westin Boston Waterfront
425
Summer Street
Boston, MA 02210
DETAILS: For media inquiries please
contact Bernadette Chepega Miller at Largemouth Communications,
(703) 297-5992, bernadette@largemouthpr.com.
ABOUT: Rho, a privately-held, contract
research organization (CRO) located in Chapel Hill, NC, provides a
full range of clinical research services across the entire drug
development process. For 30 years, Rho has been a trusted partner
to some of the industrys leading pharmaceutical, biotechnology,
and medical device companies as well as academic and government
organizations. Our commitment to excellence, our innovative
technologies, and our therapeutic expertise accelerate time to
market, maximize returns on investment, and lead to an exceptional
customer experience. For more information, please visit www.rhoworld.com and
follow us on Twitter.
###